Beierwaltes WH, Wieland DM, Yu T, Swanson DP, Mosley ST. Adrenal imaging agents: rationale, synthesis, formulation and, metabolism.
Semin Nucl Med 1978;
8:5-21. [PMID:
635596 DOI:
10.1016/s0001-2998(78)80004-x]
[Citation(s) in RCA: 37] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
In this introductory paper on radionuclide adrenal imaging, the rationale, synthesis, formulation, and metabolism of two clinically well-established and one promisinmg adrenocortical imaging agents are reviewed. Their present clinical utility is reviewed in a separate presentation in this issue. Progress to date in developing a positive imaging agent of the adrenal medulla and tumors of chromaffin tissue will be given brief consideration because there is, as yet, no clinically successful radiolabeled adrenal medulla imaging agent.
Collapse